KOY

5'-O-{3-[3-(2-carboxyphenyl)-3-oxopropyl]phenyl}adenosine

Created:	2019-01-03
Last modified:	2019-04-10

Find Related PDB Entry
1 entries where KOY is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	63
Chiral Atom Count	4
Bond Count	67
Aromatic Bond Count	22

2D diagram of KOY

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	5'-O-{3-[3-(2-carboxyphenyl)-3-oxopropyl]phenyl}adenosine
Systematic Name (OpenEye OEToolkits)	2-[3-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy]phenyl]propanoyl]benzoic acid
Formula	C₂₆ H₂₅ N₅ O₇
Molecular Weight	519.506
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c12n(cnc1c(ncn2)N)C5OC(COc4cc(CCC(c3c(C(O)=O)cccc3)=O)ccc4)C(O)C5O
SMILES	CACTVS	3.385	Nc1ncnc2n(cnc12)[CH]3O[CH](COc4cccc(CCC(=O)c5ccccc5C(O)=O)c4)[CH](O)[CH]3O
SMILES	OpenEye OEToolkits	2.0.6	c1ccc(c(c1)C(=O)CCc2cccc(c2)OCC3C(C(C(O3)n4cnc5c4ncnc5N)O)O)C(=O)O
Canonical SMILES	CACTVS	3.385	Nc1ncnc2n(cnc12)[C@@H]3O[C@H](COc4cccc(CCC(=O)c5ccccc5C(O)=O)c4)[C@@H](O)[C@H]3O
Canonical SMILES	OpenEye OEToolkits	2.0.6	c1ccc(c(c1)C(=O)CCc2cccc(c2)OC[C@@H]3[C@H]([C@H]([C@@H](O3)n4cnc5c4ncnc5N)O)O)C(=O)O
InChI	InChI	1.03	InChI=1S/C26H25N5O7/c27-23-20-24(29-12-28-23)31(13-30-20)25-22(34)21(33)19(38-25)11-37-15-5-3-4-14(10-15)8-9-18(32)16-6-1-2-7-17(16)26(35)36/h1-7,10,12-13,19,21-22,25,33-34H,8-9,11H2,(H,35,36)(H2,27,28,29)/t19-,21-,22-,25-/m1/s1
InChIKey	InChI	1.03	GEMGRSMVWNUQGG-PTGPVQHPSA-N

Related Resource References

Resource Name	Reference
PubChem	137700792

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.